Date: June 04, 2026

KMP / Board / Auditor Changes

Not Specified

Dividend Declaration or Non-Declaration

Not Specified

Board Meeting Outcomes

Not Specified

Financial Results

Not Specified

Auditor’s Report

Not Specified

Disinvestment / Strategic Actions

Not Specified

Other Operational / Legal / Strategic Disclosures

ESOP Allotment Details

The Nomination & Remuneration Committee of Laurus Labs Limited allotted 3,93,001 equity shares of ₹2 each to eligible employees on exercise of stock options on June 04, 2026.

Breakdown by ESOP Scheme:

  • Laurus Employees Stock Option Scheme 2016 (Grant-III): 245 allottees, 1,11,318 shares at exercise price of ₹350.00 per share (premium ₹348.00)
  • Laurus Employees Stock Option Scheme 2016 (Grant-IV): 1,053 allottees, 77,933 shares at exercise price of ₹301.50 per share (premium ₹299.50)
  • Laurus Employees Stock Option Scheme 2018 (Grant-III): 1 allottee, 2,500 shares at exercise price of ₹350.00 per share (premium ₹348.00)
  • Laurus Labs Employees Stock Option Scheme 2021 (Grant-I): 120 allottees, 2,01,250 shares at exercise price of ₹301.50 per share (premium ₹299.50)

Total: 1,419 allottees, 3,93,001 shares

Financial Impact:

  • Total money realized by exercise of options: ₹12,40,09,974.50
  • Total paid-up capital after allotment: ₹1,08,04,99,166 divided into 54,02,49,583 equity shares
  • Diluted earnings per share pursuant to issue: ₹13.71

Scheme Compliance:

All schemes are in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Options must be exercised within one year from the date of vesting.

No options lapsed, variations, or subsequent changes reported.

Share Details:

  • Par value: ₹2 per share
  • All shares are identical in all respects to existing shares
  • No lock-in restrictions apply
  • No listing fees payable

Distinctive Number Ranges:

  • ESOP 2016 Grant-III: 53,98,56,583 to 53,99,67,900
  • ESOP 2016 Grant-IV: 53,99,67,901 to 54,00,45,833
  • ESOP 2018 Grant-III: 54,00,45,834 to 54,00,48,333
  • ESOP 2021 Grant-I: 54,00,48,334 to 54,02,49,583

Regulatory Filings:

The disclosure is made pursuant to SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 and Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Company Information:

Listed on: BSE Limited and National Stock Exchange of India Ltd